AML induction shifts beyond 7+3 as venetoclax, hypomethylating agents, and FLT3 inhibitors drive less toxic combos and oral ...
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that ...
BOSTON, MA, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Radiance Biopharma, a clinical stage biotechnology company ...
Highly comparable biodistribution profiles of Radio-DARPin candidates labeled with imaging isotopes 177Lu or 203Pb allows for rapid expansion of ...
Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred ...
A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.
A new study coordinated by researchers at UMC Utrecht and Amsterdam UMC shows that antibodies from Long COVID patients can ...
Breast cancer precision care is accelerating via giredestrant data, ADC sequencing, and NGS/ctDNA-driven targeting, while EMR ...
A TOPOGRAPH-based hierarchy stratifies biomarker–drug pairs from regulatory/positive trial evidence (tiers 1–3A) to ...
Results from the phase 3 CLL17 trial (NCT04608318) are helping clarify the ongoing debate over continuous vs fixed-duration ...
Leapfrog Bio, a clinical-stage precision oncology company dedicated to discovering and developing novel targeted therapies ...
Amini: This varies quite a bit by stage — operable vs. nonoperable — and patients’ performance status and preference. Additionally, more relevant to medical oncology but equally, if not more, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results